Clinical Trial Update: Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vorinostat for progressive or recurrent glioblastoma multiforme has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Zolinza (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2013-07-10